Anaplastic Lymphoma KinaseBiomarkers, TumorDNA Methylation
Dr. John T. Sandlund, MD
NPI1629071204
- Publications
- 178
- Clinical trials
- 7
- Industry payments
- $38
- Insurance carriers
- 3
- State licenses
- 2
- Practice address
- 262 Danny Thomas Pl, Memphis, TN 38105-3678
- Practice phone
- Call (901) 595-3006
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Sandlund's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. John T. Sandlund is a pediatric hematology and oncology physician in Memphis, Tennessee
Dr. Sandlund practices in Memphis, Tennessee.
Dr. Sandlund's NPI, 1629071204, was assigned on May 27, 2005. Dr. Sandlund graduated from Ohio State College of Medicine in 1980. Dr. Sandlund's Tennessee license number on file is 18286.
NPI and contact details
- NPI
- 1629071204NPI Registry (opens in a new tab)
- NPI enumeration date
- May 27, 2005
- NPI status
- Active
- Practice phone
- (901) 595-3006
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Medical school graduation
- 1980
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. John T. Sandlund's practice address is in Memphis, Tennessee
Dr. Sandlund's practice address in the NPI Registry is 262 Danny Thomas Pl, Memphis, TN 38105-3678. The practice phone is (901) 595-3006.
- NPI Registry address262 Danny Thomas Pl, Memphis, TN 38105-3678Phone(901) 595-3006
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. John T. Sandlund's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sandlund practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Sandlund's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Sandlund practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. John T. Sandlund is one of 141 pediatric hematologys and oncology physicians in Tennessee
Pediatric hematology-oncology is Dr. Sandlund's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Sandlund is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Sandlund's licenses on file in 2 states: Tennessee and Maryland.
Specialties and state licenses
- Pediatric hematology and oncology, TennesseePrimary
- Maryland license
Pediatric hematologys and oncology physicians near Dr. Sandlund
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
141pediatric hematologys and oncology physicians in Tennessee100pediatric hematologys and oncology physicians in Memphis
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. John T. Sandlund has 178 publications on record
Dmand AI links 178 papers to Dr. Sandlund, published from 2000 to 2024. 2013 was the busiest year, with 8. The most frequent topics are Precursor Cell Lymphoblastic Leukemia-Lymphoma, Antineoplastic Combined Chemotherapy Protocols and Remission Induction. Dr. Sandlund has published most often in Leukemia. Dr. Sandlund's most frequent co-authors are Ching-Hon Pui, MD, Jeffrey E. Rubnitz, MD and Hiroto Inaba, MD.
Papers178
Years published2000 to 2024
Dr. Sandlund's papers by year, 2012 to 2024
Topics Dr. Sandlund writes about most
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Antineoplastic Combined Chemotherapy Protocols
- Remission Induction
- Lymphoma, Non-Hodgkin
- Methotrexate
- Burkitt Lymphoma
- Asparaginase
- Immunophenotyping
Dr. Sandlund's most frequent co-authors
- Ching-Hon Pui, MD91 shared papers
- Jeffrey E. Rubnitz, MD55 shared papers
- Hiroto Inaba, MD21 shared papers
Recent publications by Dr. Sandlund
Pediatr Blood Cancer
AnalgesicsAnalgesics, OpioidAntineoplastic Agents, Phytogenic
Antineoplastic Combined Chemotherapy ProtocolsAsparaginaseCentral Nervous System Neoplasms
Pediatr Blood Cancer
AsparaginaseDrug CompoundingHypertriglyceridemia
Cancer SurvivorsLymphoma, Non-Hodgkin
See who Dr. Sandlund researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sandlund works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. John T. Sandlund has worked on 7 clinical trials
Dmand AI links Dr. Sandlund to 7 clinical trials. 1 is still active or recruiting. Conditions studied include Dendritic Cell Sarcoma, Interdigitating, Histiocytic Disorders, Malignant and Ataxia Telangiectasia. St. Jude Children's Research Hospital sponsors the most, 6.
Clinical trials with Dr. Sandlund by phase
- 1Phase 1: 1 trial
- 1Phase 1/2: 1 trial
- 1Phase 2: 1 trial
- 1Phase 2/3: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Sandlund's trials
- Dendritic Cell Sarcoma, Interdigitating
- Histiocytic Disorders, Malignant
- Ataxia Telangiectasia
- Genetic Predisposition to Disease
- Hodgkin Disease
Investigators on the most trials with Dr. Sandlund
Recent clinical trials with Dr. Sandlund
Genetic Predisposition to DiseaseDisease Susceptibility
Mature B-Cell Lymphoma And Leukemia Study III (opens in a new tab)
Active, not recruitingPhase 2/3
Lymphoma, Non-HodgkinLymphomaCOPADCOP, COPADM8, CYVECOP, COPD M3, CYM
Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma (opens in a new tab)
TerminatedPhase 1/2
Lymphoma, Large-Cell, AnaplasticLymphoma, T-CellCarboplatinEtoposideIfosfamide
Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies (opens in a new tab)
CompletedPhase 1
Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaDexamethasoneIrinotecanVincristine
Ataxia TelangiectasiaTelangiectasisDexamethasone, procarbazinedoxorubicin, methotrexate, cyclophosphamide, L-asparaginaseEtoposide, cytarabine, mercaptopurine
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. John T. Sandlund received $38 in industry payments from 2018 to 2022
CMS Open Payments shows 2 general payments to Dr. Sandlund from 2 drug and device companies from 2018 to 2022. Food and beverage make up the largest share, 100% of the total. Janssen Research & Development, LLC paid the most, $19.
General payments to Dr. Sandlund by program year, 2018 to 2022
Companies that paid Dr. Sandlund the most, 2018 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. John T. Sandlund graduated from Ohio State College of Medicine
Dr. Sandlund graduated from Ohio State College of Medicine in 1980. Dr. Sandlund is a member of ASCO.
- Medical school
- Board certified in pediatric hematology-oncology
- Board certified in pediatrics
Source: Dmand AI Professional Profile Data
Dr. John T. Sandlund accepts plans from 3 insurance carriers
Dr. Sandlund is in network with 3 carriers, including AR State Medicaid, GA State Medicaid and KY State Medicaid. Medicaid plans come from the most carriers, 3. Check the plan with the practice before a visit.
- AR State Medicaid
- GA State Medicaid
- KY State Medicaid
Source: Dmand AI Insurance Network Data
Sources for Dr. John T. Sandlund's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. John T. Sandlund
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. John T. Sandlund's NPI number?
Dr. John T. Sandlund's NPI number is 1629071204. It was assigned on May 27, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. John T. Sandlund?
Dr. John T. Sandlund is a pediatric hematology and oncology physician in Memphis, Tennessee. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. John T. Sandlund practice?
Dr. Sandlund practices at 262 Danny Thomas Pl, Memphis, TN 38105-3678.
What is Dr. John T. Sandlund's office phone number?
The practice phone on file for Dr. Sandlund is (901) 595-3006.
What is Dr. John T. Sandlund's medical license number?
Dr. Sandlund's Tennessee license number on file is 18286, one of the licenses on file in 2 states.
Which states has Dr. John T. Sandlund been licensed in?
Dmand AI has state licenses on file for Dr. Sandlund in Tennessee (1987 to 2025) and Maryland (1984 to 1989).
Is Dr. John T. Sandlund board certified?
Yes. Dr. Sandlund is board certified in pediatric hematology-oncology by the American Board of Pediatrics.
Where did Dr. John T. Sandlund go to medical school?
Dr. Sandlund graduated from Ohio State College of Medicine in 1980.
Has Dr. John T. Sandlund received payments from drug or device companies?
CMS Open Payments shows $38 in general payments to Dr. Sandlund from 2 companies from 2018 to 2022. The largest total came from Janssen Research & Development, LLC.
How long has Dr. John T. Sandlund been practicing?
Dr. Sandlund graduated from medical school in 1980, 46 years ago.
Show 3 more questionsShow fewer questions
Does Dr. John T. Sandlund do research?
Dmand AI links 178 publications to Dr. Sandlund, published from 2000 to 2024. Dr. Sandlund has worked on 7 clinical trials.
Who does Dr. John T. Sandlund publish with?
Dr. Sandlund's most frequent co-authors are Ching-Hon Pui, MD (91 shared papers), Jeffrey E. Rubnitz, MD (55 shared papers) and Hiroto Inaba, MD (21 shared papers).
What insurance does Dr. John T. Sandlund accept?
Dr. Sandlund is in network with 3 carriers, including AR State Medicaid, GA State Medicaid and KY State Medicaid. Medicaid plans come from the most carriers, 3. Check the plan with the practice before a visit.
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Tennessee by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card